TREVILOR Side Effects

6614265-9 | Suicidal Ideation
on Feb 18, 2010 Female patient from GERMANY , 49 years of age, was diagnosed with depression (What is depression?) and was treated with Trevilor (View Usage). Patient experienced the following unwanted or unexpected effects: suicidal ideation. Trevilor dosage: For Several Years Till 25-oct-2009: 75-150 Mg/d; From 26-oct-2009 To 19-nov-2009 225 Mg/d. During the same period patient was treated with SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ). Patient was hospitalized.

6600224-9 | Hypokalaemia, Hyponatraemia
Patient was taking Trevilor (View Usage). Patient had the following side effects: hypokalaemia, hyponatraemia on Feb 18, 2010 from GERMANY Additional patient health information: Female patient , 76 years of age, . Trevilor dosage: . During the same period patient was treated with MELPERONE (View Melperone Review and Melperone Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

6587637-9 | Anaphylactic Reaction, Bundle Branch Block Left, Circulatory Collapse, Depressed Level Of Consciousness, Electrocardiogram St Segment Elevation, Respiratory Depression, Serotonin Syndrome
Adverse event was reported on Feb 11, 2010 by a Female patient taking Trevilor (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: GERMANY , weighting 172.0 lb, After Trevilor was administered, patient had the following side effects: anaphylactic reaction, bundle branch block left, circulatory collapse, depressed level of consciousness, electrocardiogram st segment elevation, respiratory depression, serotonin syndrome. During the same period patient was treated with DORMICUM (View Dormicum Review and Dormicum Label ), JATROSOM N (View Jatrosom N Review and Jatrosom N Label ), MELPERONE (View Melperone Review and Melperone Label ), L THYROXIN (View L-thyroxin Review and L-thyroxin Label ), L THYROXIN (View L-thyroxin Review and L-thyroxin Label ), L THYROXIN (View L-thyroxin Review and L-thyroxin Label ).

6584905-1 | Cystitis, Pyelonephritis, Urinary Retention
on Feb 11, 2010 Female patient from GERMANY , 48 years of age, was diagnosed with depression (What is depression?), hypertension and was treated with Trevilor (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis, pyelonephritis, urinary retention. Trevilor dosage: . During the same period patient was treated with PANTOZOL (View Pantozol Review and Pantozol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), REMERGIL (View Remergil Review and Remergil Label ). Patient was hospitalized.


6565347-1 | Hypertensive Crisis
on Jan 22, 2010 Male patient from GERMANY , 89 years of age, was diagnosed with depression (What is depression?) and was treated with Trevilor (View Usage). Patient had the following side effects: hypertensive crisis. Trevilor dosage: .

6564299-8 | Hypertensive Crisis
Patient was taking Trevilor (View Usage). After Trevilor was administered, patient had the following side effects: hypertensive crisis on Jan 22, 2010 from GERMANY Additional patient health information: Male patient , 89 years of age, was diagnosed with depression (What is depression?) and. Trevilor dosage: .

6556753-X | Dyskinesia, Paraesthesia Oral
Adverse event was reported on Jan 21, 2010 by a Male patient taking Trevilor (View Usage) (Dosage: 300 - 375 Mg Per Day) was diagnosed with depression (What is depression?) and. Location: GERMANY , 53 years of age, Patient experienced the following unwanted or unexpected effects: dyskinesia, paraesthesia oral. During the same period patient was treated with ABILIFY (15 - 30 Mg Per Day) (View Abilify Review and Abilify Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), QUILONUM SLOW RELEASE (View Quilonum - Slow Release Review and Quilonum - Slow Release Label ), TAVOR (3 - 0.5 Mg Per Day) (View Tavor Review and Tavor Label ). Patient was hospitalized.

6551359-0 | Fall, Fatigue, Pulmonary Embolism, Thrombosis
on Jan 20, 2010 Female patient from GERMANY , 73 years of age, was diagnosed with depression (What is depression?) and was treated with Trevilor (View Usage). Patient had the following side effects: fall (What is fall?), fatigue, pulmonary embolism (What is pulmonary embolism?), thrombosis. Trevilor dosage: . During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6544512-3 | Tremor
on Jan 18, 2010 Female patient from GERMANY , 43 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Trevilor (View Usage). After Trevilor was administered, patient had the following side effects: tremor. Trevilor dosage: . During the same period patient was treated with XIMOVAN (View Ximovan Review and Ximovan Label ), ABILIFY (View Abilify Review and Abilify Label ). Patient was hospitalized.

6544092-2 | Hypertensive Crisis
Patient was taking Trevilor (View Usage). Patient experienced the following unwanted or unexpected effects: hypertensive crisis on Jan 15, 2010 from GERMANY Additional patient health information: Male patient , 89 years of age, was diagnosed with depression (What is depression?) and. Trevilor dosage: .

6252440-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Condition Aggravated, Gamma-glutamyltransferase Increased
Adverse event was reported on Jun 26, 2009 by a Female patient taking Trevilor (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: GERMANY , 66 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, condition aggravated, gamma-glutamyltransferase increased. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6124776-0 | Ileus Paralytic, Intentional Overdose, Sopor, Suicide Attempt, Tachycardia
on Mar 12, 2009 Female patient from GERMANY , weighting 132.3 lb, was treated with Trevilor (View Usage). After Trevilor was administered, patient had the following side effects: ileus paralytic, intentional overdose, sopor, suicide attempt, tachycardia. Trevilor dosage: . During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), XIMOVAN (View Ximovan Review and Ximovan Label ), TAVOR (View Tavor Review and Tavor Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ). Patient was hospitalized.

5906033-8 | Blood Lactic Acid Increased, Blood Potassium Decreased, C-reactive Protein Increased, Intentional Overdose, Somnolence, Suicide Attempt
on Sep 29, 2008 Female patient from GERMANY , weighting 176.4 lb, was treated with Trevilor (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactic acid increased, blood potassium decreased, c-reactive protein increased, intentional overdose, somnolence, suicide attempt. Trevilor dosage: Overdose Amount Max. 10000 Mg. During the same period patient was treated with TOPIRAMATE (Overdose Amount Max. 7500 Mg) (View Topiramate Review and Topiramate Label ), MELPERONE (Overdose Amount Max. 2500 Mg) (View Melperone Review and Melperone Label ). Patient was hospitalized.

5885067-6 | Apnoea, Intentional Overdose, Somnolence, Suicide Attempt
Patient was taking Trevilor (View Usage). Patient had the following side effects: apnoea, intentional overdose, somnolence, suicide attempt on Sep 12, 2008 from GERMANY Additional patient health information: Female patient , weighting 198.4 lb, . Trevilor dosage: Overdose Amount 1500 Mg. During the same period patient was treated with ALCOHOL (Overdose Amount 1.5 Bottles Of Vodka) (View Alcohol Review and Alcohol Label ), TETRAZEPAM (Overdose Amount 500 Mg) (View Tetrazepam Review and Tetrazepam Label ). Patient was hospitalized.

5871293-9 | Caesarean Section, Cephalo-pelvic Disproportion, Gestational Diabetes, Unintended Pregnancy
Adverse event was reported on Aug 26, 2008 by a Female patient taking Trevilor (View Usage) (Dosage: ) was diagnosed with depressive symptom and. Location: GERMANY , 23 years of age, weighting 224.9 lb, After Trevilor was administered, patient had the following side effects: caesarean section, cephalo-pelvic disproportion, gestational diabetes, unintended pregnancy. During the same period patient was treated with BETAFERON (View Betaferon Review and Betaferon Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

5871291-5 | Nausea, Sensory Disturbance, Tachycardia
on Aug 27, 2008 Female patient from GERMANY , weighting 158.7 lb, was diagnosed with panic disorder (What is panic disorder?) and was treated with Trevilor (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), sensory disturbance, tachycardia. Trevilor dosage: . During the same period patient was treated with TRIMIPRAMINE MALEATE (View Trimipramine Maleate Review and Trimipramine Maleate Label ). Patient was hospitalized.

5858573-8 | Blood Creatinine Increased, Blood Urea Increased, Dehydration, Depressed Level Of Consciousness, Dysarthria, Hypertension, Intentional Overdose, Suicide Attempt
on Aug 25, 2008 Female patient from GERMANY , weighting 176.4 lb, was treated with Trevilor (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, dehydration, depressed level of consciousness, dysarthria, hypertension, intentional overdose, suicide attempt. Trevilor dosage: . During the same period patient was treated with ZOPICLONE (20 Tablets (overdose Amount 150 Mg)) (View Zopiclone Review and Zopiclone Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

5851227-3 | Apnoea, Intentional Overdose, Somnolence, Suicide Attempt
Patient was taking Trevilor (View Usage). After Trevilor was administered, patient had the following side effects: apnoea, intentional overdose, somnolence, suicide attempt on Aug 15, 2008 from GERMANY Additional patient health information: Female patient , weighting 198.4 lb, . Trevilor dosage: Overdose Amount 1500 Mg. During the same period patient was treated with ALCOHOL (Overdose Amount 1.5 Bottles Of Vodka) (View Alcohol Review and Alcohol Label ), TETRAZEPAM (Overdose Amount 500 Mg) (View Tetrazepam Review and Tetrazepam Label ). Patient was hospitalized.

5843446-7 | Depressed Level Of Consciousness, Dysarthria, Intentional Overdose, Suicide Attempt
Adverse event was reported on Aug 11, 2008 by a Male patient taking Trevilor (View Usage) (Dosage: ) . Location: GERMANY , weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, dysarthria, intentional overdose, suicide attempt. During the same period patient was treated with ZOPICLONE (20 Tablets (overdose Amount 150 Mg)) (View Zopiclone Review and Zopiclone Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

5812164-3 | Fatigue, Gastrointestinal Sounds Abnormal, Intentional Overdose, Suicide Attempt
on Jul 14, 2008 Male patient from GERMANY , weighting 165.3 lb, was treated with Trevilor (View Usage). Patient had the following side effects: fatigue, gastrointestinal sounds abnormal, intentional overdose, suicide attempt. Trevilor dosage: 10 Tablets/capsules (overdose Amount 375 Mg). During the same period patient was treated with ALCOHOL (1 Bottle Of Sparkling Wine) (View Alcohol Review and Alcohol Label ), CITALOPRAM HYDROBROMIDE (Max. 40 Tablets (overdose Amount Max. 800 Mg)) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

5656562-X | Micturition Disorder
on Mar 05, 2008 Male patient from GERMANY , weighting 156.5 lb, was diagnosed with depression (What is depression?) and was treated with Trevilor (View Usage). After Trevilor was administered, patient had the following side effects: micturition disorder. Trevilor dosage: 187.5mg Per Day. During the same period patient was treated with MIRTAZAPINE (30 Mg Per Day) (View Mirtazapine Review and Mirtazapine Label ), LITHIUM CARBONATE (900mg Per Day) (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

5631656-3 | Alcohol Abuse, Diabetes Mellitus, Weight Increased
Patient was taking Trevilor (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol abuse, diabetes mellitus, weight increased on Feb 08, 2008 from GERMANY Additional patient health information: Male patient , 49 years of age, . Trevilor dosage: . During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), QUILONIUM R (View Quilonium-r Review and Quilonium-r Label ).

5630166-7 | Intentional Overdose, Somnolence, Status Epilepticus, Suicide Attempt
Adverse event was reported on Feb 08, 2008 by a Female patient taking Trevilor (View Usage) (Dosage: ) . Location: GERMANY , weighting 209.4 lb, Patient had the following side effects: intentional overdose, somnolence, status epilepticus, suicide attempt. During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ), OXCARBAZEPINE (View Oxcarbazepine Review and Oxcarbazepine Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), TOPAMAX (7 Tablets (overdose Amount 350 Mg)) (View Topamax Review and Topamax Label ). Patient was hospitalized.

5585162-5 | Intentional Overdose, Status Epilepticus
on Jan 04, 2008 Female patient from GERMANY , weighting 198.4 lb, was treated with Trevilor (View Usage). After Trevilor was administered, patient had the following side effects: intentional overdose, status epilepticus. Trevilor dosage: . During the same period patient was treated with TOPAMAX (7 Tablets (overdose Amount 350 Mg)) (View Topamax Review and Topamax Label ), OXCARBAZEPINE (View Oxcarbazepine Review and Oxcarbazepine Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ). Patient was hospitalized.

5584223-4 | Abnormal Behaviour, Alcohol Interaction, Amnesia, Blood Alcohol Increased, Road Traffic Accident
on Dec 24, 2007 Male patient from GERMANY , 26 years of age, was diagnosed with depression (What is depression?) and was treated with Trevilor (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, alcohol interaction, amnesia, blood alcohol increased, road traffic accident. Trevilor dosage: . During the same period patient was treated with ALCOHOL (View Alcohol Review and Alcohol Label ).

5566422-0 | Condition Aggravated, Hepatic Enzyme Increased
Patient was taking Trevilor (View Usage). Patient had the following side effects: condition aggravated, hepatic enzyme increased on Dec 17, 2007 from GERMANY Additional patient health information: Male patient , 75 years of age, . Trevilor dosage: 37.5 Mg. During the same period patient was treated with RISPERDAL (1 Mg) (View Risperdal Review and Risperdal Label ), ACETYLSALICYLIC ACID SRT (100 Mg) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), MIRTAZAPINE (45 Mg) (View Mirtazapine Review and Mirtazapine Label ).

5537240-4 | Angina Pectoris, Blood Creatine Phosphokinase Increased, Blood Pressure Increased, Electrocardiogram St Segment Depression, Hepatic Steatosis, Hepatitis A, Hepatitis B, Hypoaesthesia, Mitral Valve Incompetence
Adverse event was reported on Nov 29, 2007 by a Male patient taking Trevilor (View Usage) (Dosage: ) . Location: GERMANY , weighting 130.1 lb, After Trevilor was administered, patient had the following side effects: angina pectoris, blood creatine phosphokinase increased, blood pressure increased, electrocardiogram st segment depression, hepatic steatosis, hepatitis a (What is hepatitis a?), hepatitis b (What is hepatitis b?), hypoaesthesia, mitral valve incompetence. During the same period patient was treated with BERLINSULIN L (View Berlinsulin L Review and Berlinsulin L Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), HEPA MERZ (View Hepa-merz Review and Hepa-merz Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), LOCOL (View Locol Review and Locol Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), NOVONORM (View Novonorm Review and Novonorm Label ). Patient was hospitalized.

5525089-8 | Coma, Intentional Overdose, Respiratory Depression
on Nov 21, 2007 Female patient from GERMANY , weighting 154.3 lb, was treated with Trevilor (View Usage). Patient experienced the following unwanted or unexpected effects: coma, intentional overdose, respiratory depression. Trevilor dosage: . During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

5521121-6 | Rash Maculo-papular, Urticaria
on Nov 12, 2007 Female patient from GERMANY , weighting 121.3 lb, was diagnosed with bipolar i disorder and was treated with Trevilor (View Usage). Patient had the following side effects: rash maculo-papular, urticaria. Trevilor dosage: . During the same period patient was treated with QUILONIUM R (View Quilonium-r Review and Quilonium-r Label ), QUILONIUM R (View Quilonium-r Review and Quilonium-r Label ), QUILONIUM R (View Quilonium-r Review and Quilonium-r Label ), ERGENYL (View Ergenyl Review and Ergenyl Label ), ELMENDOS (View Elmendos Review and Elmendos Label ). Patient was hospitalized.

5472487-7 | Intentional Overdose, Somnolence
Patient was taking Trevilor (View Usage). After Trevilor was administered, patient had the following side effects: intentional overdose, somnolence on Sep 26, 2007 from GERMANY Additional patient health information: Female patient , weighting 116.8 lb, . Trevilor dosage: . During the same period patient was treated with CETIRIZINE HCL (5 Tablets) (View Cetirizine Hcl Review and Cetirizine Hcl Label ), ALCOHOL (View Alcohol Review and Alcohol Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), PARACETAMOL (20 Tablets (overdose Amount 10000 Mg)) (View Paracetamol Review and Paracetamol Label ), ASPIRIN (1 Tablet) (View Aspirin Review and Aspirin Label ), DIAZEPAM (25 Ml) (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

5376293-3 | Neonatal Infection
Adverse event was reported on Jun 26, 2007 by a Male patient taking Trevilor (View Usage) (Dosage: ) was diagnosed with post-traumatic stress disorder (What is post-traumatic stress disorder?), depression (What is depression?) and. Location: GERMANY , weighting 8.38 lb, Patient experienced the following unwanted or unexpected effects: neonatal infection. Patient was hospitalized.

4975595-X | Alanine Aminotransferase Increased, Gamma-glutamyltransferase Increased
on Mar 30, 2006 Female patient from GERMANY , 43 years of age, was diagnosed with schizophrenia and was treated with Trevilor (View Usage). Patient had the following side effects: alanine aminotransferase increased, gamma-glutamyltransferase increased. Trevilor dosage: See Image, Oral. During the same period patient was treated with ZYPREXA (12.5 Mg Per Day, Oral) (View Zyprexa Review and Zyprexa Label ).

4717194-0 | Abdominal Tenderness, B-lymphocyte Count Decreased, Biopsy Bone Marrow Abnormal, Blood Cholesterol Increased, Blood Glucose Increased, Blood Immunoglobulin A Decreased, Blood Immunoglobulin G Decreased, Blood Immunoglobulin M Decreased, Blood Uric Acid Increased
on Apr 08, 2005 Male patient from GERMANY , 50 years of age, weighting 165.3 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Trevilor (View Usage). After Trevilor was administered, patient had the following side effects: abdominal tenderness, b-lymphocyte count decreased, biopsy bone marrow abnormal, blood cholesterol increased, blood glucose increased, blood immunoglobulin a decreased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, blood uric acid increased. Trevilor dosage: 150 Mg/day. During the same period patient was treated with TEGRETOL (400 Mg, Bid) (View Tegretol Review and Tegretol Label ). Patient was hospitalized and became disabled.

4708494-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
Patient was taking Trevilor (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased on Jun 27, 2005 from GERMANY Additional patient health information: Male patient , 63 years of age, was diagnosed with depression (What is depression?) and. Trevilor dosage: See Image. During the same period patient was treated with REMERGIL (MIRTAZAPINE) (See Image) (View Remergil (mirtazapine) Review and Remergil (mirtazapine) Label ), STANGYL (TRIMIPRAMINE MALEATE) (See Image) (View Stangyl (trimipramine Maleate) Review and Stangyl (trimipramine Maleate) Label ), ZYPREXA (20 Mg Oral) (View Zyprexa Review and Zyprexa Label ).

4664339-7 | Abdominal Tenderness, B-lymphocyte Count Decreased, Biopsy Bone Marrow Abnormal, Blood Immunoglobulin A Decreased, Blood Immunoglobulin G Decreased, Blood Immunoglobulin M Decreased, Bone Marrow Depression, Bronchitis, Cardiac Murmur
Adverse event was reported on Apr 08, 2005 by a Male patient taking Trevilor (View Usage) (Dosage: 150 Mg/day) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: , 50 years of age, weighting 165.3 lb, Patient had the following side effects: abdominal tenderness, b-lymphocyte count decreased, biopsy bone marrow abnormal, blood immunoglobulin a decreased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, bone marrow depression, bronchitis (What is bronchitis?), cardiac murmur. During the same period patient was treated with TEGRETOL (400 Mg, Bid) (View Tegretol Review and Tegretol Label ). Patient was hospitalized and became disabled.